4th Covalent Drug Discovery & Development Summit
Hosted by Hanson Wade
- 20 – 22 October 2026
Add to calendar
Welcome to kongre.net - Hampton Inn Boston Seaport District, Boston, United States of America
- Health SciencesPharmacy & Pharmaceutical Sciences
Let others know you'll be there. This does not register you for the event.
Registration
Registration is handled by the organiser
Fees are listed on this page
View registration detailsKey facts
4th Covalent Drug Discovery & Development Summit is a summit held 20 – 22 October 2026 in Hampton Inn Boston Seaport District, Boston, United States of America, organised by Hanson Wade.
- Dates:
- 20 – 22 October 2026
- Format:
- In person
- Venue:
- Hampton Inn Boston Seaport District, Boston, United States of America
- Subjects:
- Pharmacy & Pharmaceutical Sciences
- Organiser:
- Hanson Wade
- Official website:
- covalent-drug-discovery.com
Returning for its 4th year, the Covalent Drug Discovery & Development Summit is an industry forum dedicated entirely to advancing covalent therapeutics end-to-end, from early discovery through to IND and early clinical development. Organized by Hanson Wade, the event takes place from October 20-22, 2026, in Boston, MA. It unites international biopharma leaders, researchers, and academic experts to deliver data-driven case studies, translational strategies, and insights into overcoming selectivity, safety, and PK/PD challenges in covalent drug development.
Conference theme
Programme highlights
View full programme- Tue, 20 Oct 2026Workshop A: Transforming Covalent Warhead Design by Aligning Chemistry with Developability & Translational Expectations to Accelerate Progression Towards INDWorkshop2 sessions this day
- Wed, 21 Oct 2026Chair’s Opening RemarksPlenary13 sessions this day
- Thu, 22 Oct 2026Chair’s Closing RemarksPlenary10 sessions this day
Speakers
View all 22 speakersThe University of Texas at Austin
Leveraging Covalent Metabolic Targeting to Deliver Next-Generation Precision Therapeutics via Electrophile-Drug ConjugatesDana-Farber Cancer Institute
Targeting A Non-Traditional Residue to Reprogram E3 Ligase Function & Degradation Profiles
Organiser and contact
Contact
- Event secretary:
- Deeya Gurung
- Email:
- [email protected]
Advertisement
Related events
- 8th Exosome-Based Therapeutics Development SummitBoston, United States of America22–24 Sept 2026
- Ion Channel-Targeted Drug Development SummitBoston, United States of America23–24 Sept 2026
- Finance & Accounting for BioscienceBoston, United States of America24–25 Sept 2026
- Integrative Structural Biology: Bridging Fields, Techniques, and ScalesBreckenridge, United States of America28 Sept 2026 – 1 Oct 2026
- 20th Annual Pain Therapeutics SummitBurlingame, United States of America28–29 Sept 2026
- 10th IPF SummitBoston, United States of America29 Sept 2026 – 1 Oct 2026